Literature DB >> 22974929

Lung cancer in patients with lung transplants.

D Espinosa1, C Baamonde, J Illana, E Arango, G Carrasco, P Moreno, F J Algar, A Alvarez, F Cerezo, F Santos, J M Vaquero, J Redel, A Salvatierra.   

Abstract

OBJECTIVE: The aim of our study was to describe the incidence of lung cancer in patients after lung transplantation (LT).
MATERIALS AND METHODS: We performed an observational, retrospective, descriptive study based on data from 340 patients undergoing lung transplantation between October 1993 and December 2010. We collected data about the donors, recipients, intra- and postoperative periods, and survivals.
RESULTS: We identified 9 (2.6%) patients who developed lung cancer after LT. Their average age was 56 ± 9.3 years (range, 18-63). All cases were men with 8/9 (88.8%) having received a single lung transplant. All cancers developed in the native lung. The indications for transplantation were: emphysema type chronic obstructive pulmonary disease (COPD; n = 5), idiopathic pulmonary fibrosis (n = 3), or cystic fibrosis (n = 1); 77% of them were former smokers. All of the COPD patient were affected. The interval from transplantation to diagnosis was 53.3 ± 12 months (range 24-86). Survival after cancer diagnosis was 49.3 ± 6.3 (range = 0-180) months.
CONCLUSIONS: LT was associated with a relatively high incidence of lung cancer, particularly in the native lung. In our series, lung cancer was related more to patients with emphysema-type COPD and a history of smoking. We believe that these patients should be closely followed to establish the diagnosis and apply early treatment.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22974929     DOI: 10.1016/j.transproceed.2012.07.067

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  3 in total

Review 1.  Lung cancer: a rare indication for, but frequent complication after lung transplantation.

Authors:  Dirk Van Raemdonck; Robin Vos; Jonas Yserbyt; Herbert Decaluwe; Paul De Leyn; Geert M Verleden
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

2.  Tacrolimus Levels Are Not Associated with Risk of Malignancy in Lung Transplant Recipients.

Authors:  Benjamin Daniel Fox; Fadi Ashquar; Yael Raviv; Dror Rozengarten; Osnat Straichman; Shimon Izhakian; Mordechai Reuven Kramer
Journal:  Ann Transplant       Date:  2017-11-14       Impact factor: 1.530

Review 3.  Lung cancer in recipients after lung transplant: single-centre experience and literature review.

Authors:  Bilal Haider Lashari; Robert J Vender; Derlis Christian Fleitas-Sosa; Tejas Sinha; Gerard J Criner
Journal:  BMJ Open Respir Res       Date:  2022-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.